Keyword

tariquidar

Description: A drug compound that inhibits P-glycoprotein and is investigated for overcoming multidrug resistance in cancer and other settings.
Wikidata ID: wiki/Q7686198
OpenAlex ID: keywords/tariquidar
2008 · Sven Rottenberg, Janneke E. Jaspers, et al. · Proceedings of the National Academy of Sciences · 1,056
2012 · A. Palmeira, E. Sousa, et al. · Current Medicinal Chemistry · 545
2004 · Robert W. Robey, Kenneth Steadman, et al. · Cancer Research · 392
2007 · Elizabeth Fox, Susan E Bates · Expert Review of Anticancer Therapy · 390
2018 · Scott M. Jackson, Ioannis Manolaridis, et al. · Nature Structural & Molecular Biology · 350
2009 · Yogesh Patil, Tanmoy Sadhukha, et al. · Journal of Controlled Release · 335
2008 · Carlos Luna-Tortós, Maren Fedrowitz, et al. · Neuropharmacology · 330
2020 · Kamil Nosol, Ksenija Romane, et al. · Proceedings of the National Academy of Sciences · 261
2018 · Raleigh M. Linville, Jackson G. DeStefano, et al. · Biomaterials · 214
2013 · Maria Feldmann, Marie-Claude Asselin, et al. · The Lancet Neurology · 199
2017 · Prashant Joshi, Ram A. Vishwakarma, et al. · European Journal of Medicinal Chemistry · 194
2011 · Niravkumar R. Patel, Alok Rathi, et al. · International Journal of Pharmaceutics · 187
2011 · Naseem Akhtar, Abdul Ahad, et al. · Expert Opinion on Therapeutic Patents · 147
Works count: 556
Citation count: 17,650
Year
Topic
Type